Endocrine Flashcards
How may patients with PTC have microscopic nodal disease at presentation?
80%. Does NOT require prophylactic compartment surgery.
Frequency medullary thyroid cancer
5-10% of primary thyroid malignancies
Frequency Hurthle cell cancer
3-4% of primary thyroid malignancies
Frequency anaplastic thyroid cancer
1-2% of primary thyroid malignancies
In what animal was the parathyroid first identified?
Rhinoceros
Definition of Bethesda III and risk of malignancy
Atypical follicular lesion of uncertain significance, 5-15%
Size cutoff for adrenal incidentalomas prior to resection
4cm
Gene associated with medullary thyroid cancer
RET
Percentage of thyroid nodules found to be malignant
5%
How many patients with PTC have macronodular nodal disease at presentation?
35%
Position of inferior parathyroid gland in relation to RLN and inferior thyroid artery
Anterior to RLN, 1cm inferior to inferior thyroid artery
Sensitivity of sestamibi and concordant neck ultrasound in localizing single parathyroid adenoma
94-99%
Frequency papillary thyroid cancer
80% of primary thyroid malignancies
Definition of Bethesda IV and risk of malignancy
Follicular lesion or follicular neoplasm, 15-30%
Definition of Bethesda VI and risk of malignancy
Malignant, 97-99%
When should prophylactic thyroidectomy be done in patients with MEN 2B?
Within first year of life
Von Graefe’s sign
Lagging of the upper eyelid on downward rotation of the eye, indicating exophthalmic goiter (Graves’ disease)
10y survival PTC
90%
Management: Bethesda III
Repeat FNA
Atypical follicular lesion of uncertain significance
Management: Bethesda VI
Total thyroidectomy
Malignant
Globus sensation
Sensation of having a lump in the throat
Definition of Bethesda V and risk of malignancy
Suspicious for malignancy, 60-75%